ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Alabama » Internal Medicine

Top Internal Medicine Prescribers in Alabama

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JESSE MORRISS MD

Internal Medicine

44,201

$2.48M

1622
1353 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

20%
patients receiving schedule three controlled substances

Avg: 19%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$56
Average prescription price

Avg: $51

GARY HOWARD M.D.

Internal Medicine

41,527

$2.04M

919
490 are 65+

29%
patients receiving schedule two controlled substances

Avg: 4%

33%
patients receiving schedule three controlled substances

Avg: 19%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $51

WILLIAM ALLDREDGE M.D.

Internal Medicine

37,459

$1.99M

1164
889 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

26%
patients receiving schedule three controlled substances

Avg: 19%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $51

BYRON NELSON MD

Internal Medicine

37,157

$1.97M

934
649 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

36%
patients receiving schedule three controlled substances

Avg: 19%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $51

CLAUDE OSULA M.D.

Internal Medicine

36,095

$1.49M

1063
760 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

22%
patients receiving schedule three controlled substances

Avg: 19%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$41
Average prescription price

Avg: $51

VENKATAPURAM REDDY M.D.

Internal Medicine

34,246

$1.4M

926
677 are 65+

2%
patients receiving schedule two controlled substances

Avg: 4%

17%
patients receiving schedule three controlled substances

Avg: 19%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$41
Average prescription price

Avg: $51

CECIL PARKER MD

Internal Medicine

34,125

$1.46M

719
395 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

59%
patients receiving schedule three controlled substances

Avg: 19%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$43
Average prescription price

Avg: $51

OLUWOLE AKISANYA M.D.

Internal Medicine

34,003

$1.53M

814
447 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

50%
patients receiving schedule three controlled substances

Avg: 19%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $51

SAMUEL WALKER M.D.

Internal Medicine

32,934

$1.35M

705
512 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

30%
patients receiving schedule three controlled substances

Avg: 19%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$41
Average prescription price

Avg: $51

EDWARD CARLOS MD

Internal Medicine

32,805

$1.52M

1062
759 are 65+

1%
patients receiving schedule two controlled substances

Avg: 4%

26%
patients receiving schedule three controlled substances

Avg: 19%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $51

ROMMEL GO M.D.

Internal Medicine

32,691

$1.56M

1256
603 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

41%
patients receiving schedule three controlled substances

Avg: 19%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $51

JAMES SULLIVAN MD

Internal Medicine

32,593

$3.24M

949
338 are 65+

16%
patients receiving schedule two controlled substances

Avg: 4%

68%
patients receiving schedule three controlled substances

Avg: 19%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 23%

$100
Average prescription price

Avg: $51

CARMELO MENDIOLA MD

Internal Medicine

32,534

$1.94M

1016
748 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

23%
patients receiving schedule three controlled substances

Avg: 19%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$60
Average prescription price

Avg: $51

KENNY SMITH M.D.

Internal Medicine

31,292

$1.91M

620
337 are 65+

19%
patients receiving schedule two controlled substances

Avg: 4%

49%
patients receiving schedule three controlled substances

Avg: 19%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $51

MOHAMMAD ISMAIL MD

Internal Medicine

31,099

$1.84M

808
428 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

35%
patients receiving schedule three controlled substances

Avg: 19%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $51

DONALD SANDERS MD

Internal Medicine

30,779

$1.61M

1078
845 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

24%
patients receiving schedule three controlled substances

Avg: 19%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $51

CHARLES HOOD MD

Internal Medicine

30,394

$1.45M

789
527 are 65+

18%
patients receiving schedule two controlled substances

Avg: 4%

50%
patients receiving schedule three controlled substances

Avg: 19%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $51

RAYMOND BROUGHTON MD

Internal Medicine

28,785

$1.16M

1063
641 are 65+

2%
patients receiving schedule two controlled substances

Avg: 4%

29%
patients receiving schedule three controlled substances

Avg: 19%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$40
Average prescription price

Avg: $51

DAVID KNAPP M. D.

Internal Medicine

28,365

$1.23M

900
578 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

20%
patients receiving schedule three controlled substances

Avg: 19%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$43
Average prescription price

Avg: $51

NOLAN HUDSON M.D.

Internal Medicine

28,091

$1.04M

844
694 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

37%
patients receiving schedule three controlled substances

Avg: 19%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 23%

$37
Average prescription price

Avg: $51

REX BUTLER M.D.

Internal Medicine

27,973

$1.38M

648
429 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

40%
patients receiving schedule three controlled substances

Avg: 19%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $51

JOSEPH DOWNS M.D.

Internal Medicine

27,693

$1.34M

708
531 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

27%
patients receiving schedule three controlled substances

Avg: 19%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $51

ADEEB THOMAS M.D.

Internal Medicine

27,369

$1.24M

825
676 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

22%
patients receiving schedule three controlled substances

Avg: 19%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $51

MICHAEL BRASFIELD M.D.

Internal Medicine

27,158

$1.14M

562
262 are 65+

29%
patients receiving schedule two controlled substances

Avg: 4%

55%
patients receiving schedule three controlled substances

Avg: 19%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 23%

$42
Average prescription price

Avg: $51

JOHN FARLEY M.D.

Internal Medicine

27,058

$1.25M

932
835 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 19%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $51

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank